Palvella Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	57.98	83.6	7.35	38.64	117.76
Short-Term Investments	-	-	-	20.53	-
Cash & Short-Term Investments	57.98	83.6	7.35	59.17	117.76
Cash Growth	-30.64%	1037.44%	-87.58%	-49.76%	67.19%
Accounts Receivable	-	0.36	-	5.81	3.31
Other Receivables	-	1.98	-	5.23	-
Total Trade Receivables	-	2.34	-	11.04	3.31
Other Current Assets	1.01	2.3	0.2	3.21	6.55
Total Current Assets	58.99	88.23	7.55	73.42	127.63
Net Property, Plant & Equipment	-	-	-	20.7	23.03
Other Long-Term Assets	-	-	-	1.37	2.9
Total Assets	59.56	88.23	7.55	95.49	153.56
Accounts Payable	4.6	4.59	0.94	4.15	8.61
Accrued Expenses	4.35	5.47	1.42	10.75	16.84
Current Portion of Leases	0.2	-	-	0.86	-
Unearned Revenue	-	-	-	20.82	25.12
Other Current Liabilities	2.2	1.98	-	-	-
Total Current Liabilities	11.34	12.04	2.36	36.58	50.56
Long-Term Leases	0.43	-	-	12.24	13.84
Other Long-Term Liabilities	19.8	13.59	9.07	18.73	38.4
Total Long-Term Liabilities	20.23	13.59	9.07	30.98	52.24
Total Liabilities	31.58	25.63	11.43	67.56	102.81
Preferred Stock	-	-	70.6	-	-
Common Stock	0.01	0.01	-	0.07	0.07
Additional Paid-in Capital	163.34	156.33	1.82	318.53	307
Accumulated Other Comprehensive Income	0.08	0	-	-0.25	0.83
Retained Earnings	-135.45	-93.74	-76.3	-290.42	-257.14
Shareholders' Equity	27.98	62.61	-74.48	27.93	50.76
Total Liabilities & Equity	59.56	88.23	7.55	95.49	153.56
Total Debt	0.63	0	0	13.1	13.84
Net Cash (Debt)	57.35	83.6	7.35	46.07	103.92
Net Cash Growth	-31.40%	1037.44%	-84.05%	-55.67%	90.67%
Net Cash Per Share	5.10	37.56	4.10	8.05	128.80
Book Value	27.98	62.61	-74.48	27.93	50.76
Book Value Per Share	2.49	28.13	-41.52	4.88	62.91
Tangible Book Value	27.98	62.61	-74.48	27.93	50.76
Tangible Book Value Per Share	2.49	28.13	-41.52	4.88	62.91

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q